NASDAQ:LRMR

Larimar Therapeutics

Stock

USD

Last Close

8.05

30/08 20:00

Market Cap

584.11M

Beta: 0.17

Volume Today

162.95K

Avg: 214.37K

PE Ratio

−8.34

PFCF: −12.08

Overview Analysis Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue
cost of revenue						78K -	155K 98.72%	326K 110.32%	272K 16.56%	311K 14.34%
gross profit						-78K -	-155K 98.72%	-326K 110.32%	-272K 16.56%	-311K 14.34%
selling and marketing expenses
general and administrative expenses	8.14M -	19.20M 135.78%	18.29M 4.72%	12.16M 33.51%	13.19M 8.50%	2.42M 81.63%	11.40M 370.17%	12.07M 5.90%	12.28M 1.72%
selling general and administrative expenses	8.14M -	19.20M 135.78%	18.29M 4.72%	12.16M 33.51%	13.19M 8.50%	2.42M 81.63%	11.40M 370.17%	12.07M 5.90%	12.28M 1.72%	14.09M 14.76%
research and development expenses	27.39M -	54.62M 99.40%	39.94M 26.88%	40.84M 2.26%	47.93M 17.36%	20.79M 56.62%	31.41M 51.07%	38.40M 22.25%	24.25M 36.84%	27.36M 12.82%
other expenses						82K -	322K 292.68%	-171K 153.11%	1.17M 784.80%
cost and expenses	35.53M -	73.81M 107.74%	58.23M 21.12%	53.00M 8.98%	61.12M 15.33%	23.21M 62.02%	42.80M 84.39%	50.47M 17.90%	36.53M 27.62%	41.76M 14.32%
operating expenses	35.53M -	73.81M 107.74%	58.23M 21.12%	53.00M 8.98%	61.12M 15.33%	23.21M 62.02%	42.80M 84.39%	50.47M 17.90%	36.53M 27.62%	41.45M 13.47%
interest expense	-870K -	-473K 45.63%	347K 173.36%	971K 179.83%	-246K 125.33%	-1.77M 617.89%			-318K -
ebitda	-35.53M -	-74.69M 110.20%	-57.32M 23.26%	-50.87M 11.25%	-61.35M 20.61%	-23.14M 62.29%	-42.80M 85.01%	-50.47M 17.90%	-36.53M 27.62%	-41.45M 13.47%
operating income	-35.53M -	-73.81M 107.74%	-58.23M 21.12%	-53.00M 8.98%	-61.12M 15.33%	-23.21M 62.02%	-42.80M 84.39%	-50.47M 17.90%	-36.53M 27.62%	-41.76M 14.32%
depreciation and amortization		70K -	212K 202.86%	188K 11.32%	261K 38.83%	78K 70.11%	155K 98.72%	326K 110.32%	318K 2.45%	311K 2.20%
total other income expenses net	-1.04M -	-473K 54.43%	347K 173.36%	971K 179.83%	-246K 125.33%	82K 133.33%	322K 292.68%	-171K 153.11%	1.17M 784.80%	4.81M 310.67%
income before tax	-36.57M -	-74.29M 103.13%	-57.88M 22.09%	-52.03M 10.11%	-61.37M 17.95%	-23.13M 62.31%	-42.48M 83.65%	-50.64M 19.19%	-35.35M 30.18%	-36.95M 4.51%
income tax expense		-946K -	694K 173.36%	1.94M 179.83%	-492K 125.33%		-155K -	-326K 110.32%	-1.17M 259.20%
net income	-36.57M -	-74.29M 103.13%	-57.88M 22.09%	-52.03M 10.11%	-61.37M 17.95%	-23.13M 62.31%	-42.33M 82.98%	-50.31M 18.86%	-34.18M 32.05%	-36.95M 8.09%
weighted average shs out	12.19B -	2.23M 99.98%	2.27M 2.03%	2.29M 0.50%	2.69M 17.48%	507.60K 81.10%	11.88M 2,241.03%	17.16M 44.44%	25.76M 50.09%	43.90M 70.41%
weighted average shs out dil	12.19B -	2.23M 99.98%	2.27M 2.03%	2.29M 0.50%	2.69M 17.48%	507.60K 81.10%	11.88M 2,241.03%	17.16M 44.44%	25.76M 50.09%	43.90M 70.41%
eps	-0.00 -	-33.32 1,110,566.67%	-25.44 23.65%	-22.76 10.53%	-22.85 0.40%	-45.57 99.43%	-3.56 92.19%	-2.93 17.70%	-1.33 54.61%	-0.84 36.84%
epsdiluted	-0.00 -	-33.32 1,110,566.67%	-25.44 23.65%	-22.76 10.53%	-22.85 0.40%	-45.57 99.43%	-3.56 92.19%	-2.93 17.70%	-1.33 54.61%	-0.84 36.84%

All numbers in USD (except ratios and percentages)